Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?

TheFly reported on July 6 that Evercore ISI analyst Daniel Markowitz reduced the price target on TMDX to $90 from $100 while ...

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. United Therapeutics Corporation ...
The Scientist

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company

The tailor-made comprehensive offering spans a diversified clinical and commercial portfolio of innovative modalities, ...